Literature DB >> 12642472

Glucuronides of tea catechins: enzymology of biosynthesis and biological activities.

Hong Lu1, Xiaofeng Meng, Chuan Li, Shengmin Sang, Christopher Patten, Shuqun Sheng, Jungil Hong, Naisheng Bai, Bozena Winnik, Chi-Tang Ho, Chung S Yang.   

Abstract

(-)-Epigallocatechin gallate (EGCG) and (-)-epigallocatechin (EGC) are major green tea catechins with antioxidant and anticancer activities. In this study, we characterized the glucuronidation of EGCG and EGC in human, mouse, and rat microsomes and by nine different human UGT 1A and 2B isozymes expressed in insect cells. Six EGCG and EGC glucuronides were biosynthesized, and their structures were identified for the first time. (-)-EGCG-4"-O-glucuronide was the major EGCG glucuronide formed in all incubations. The catalytic efficiency (V(max)/K(m)) for (-)-EGCG-4"-O-glucuronide formation followed the order: mouse intestine > mouse liver > human liver > rat liver >> rat small intestine. The UGT-catalyzed glucuronidation of EGC was much lower than that of EGCG. The V(max)/K(m) for (-)-EGC-3'-O-glucuronide followed the following order: mouse liver > human liver > rat liver > rat and mouse small intestine. Human UGT1A1, 1A8, and 1A9 had high activities with EGCG. UGT1A8, an intestine-specific UGT, had the highest V(max)/K(m) for EGCG but low activity with EGC. Mice appeared to be more similar to humans than rats to humans in the glucuronidation of EGCG and EGC. Some of these catechin glucuronides retained the activities of their parent compounds in radical scavenging and in inhibiting the release of arachidonic acid from HT-29 human colon cancer cells. These results provide foundations for understanding the biotransformation and biological activities of tea catechins.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12642472     DOI: 10.1124/dmd.31.4.452

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  43 in total

1.  Inhibitory effects of commonly used herbal extracts on UDP-glucuronosyltransferase 1A4, 1A6, and 1A9 enzyme activities.

Authors:  Mohamed-Eslam F Mohamed; Reginald F Frye
Journal:  Drug Metab Dispos       Date:  2011-06-01       Impact factor: 3.922

Review 2.  Impact on DNA methylation in cancer prevention and therapy by bioactive dietary components.

Authors:  Y Li; T O Tollefsbol
Journal:  Curr Med Chem       Date:  2010       Impact factor: 4.530

3.  Method for the Compound Annotation of Conjugates in Nontargeted Metabolomics Using Accurate Mass Spectrometry, Multistage Product Ion Spectra and Compound Database Searching.

Authors:  Tairo Ogura; Takeshi Bamba; Akihiro Tai; Eiichiro Fukusaki
Journal:  Mass Spectrom (Tokyo)       Date:  2015-03-26

Review 4.  The pharmokinetic limitations of antioxidant treatment for COPD.

Authors:  Robert Foronjy; Alison Wallace; Jeanine D'Armiento
Journal:  Pulm Pharmacol Ther       Date:  2007-10-23       Impact factor: 3.410

5.  Hepatotoxicity of high oral dose (-)-epigallocatechin-3-gallate in mice.

Authors:  Joshua D Lambert; Mary J Kennett; Shengmin Sang; Kenneth R Reuhl; Jihyeung Ju; Chung S Yang
Journal:  Food Chem Toxicol       Date:  2009-10-31       Impact factor: 6.023

Review 6.  Regioselective sulfation and glucuronidation of phenolics: insights into the structural basis.

Authors:  Baojian Wu; Sumit Basu; Shengnan Meng; Xiaoqiang Wang; Ming Hu
Journal:  Curr Drug Metab       Date:  2011-11       Impact factor: 3.731

7.  Sustained Release of Green Tea Polyphenols from Liposomal Nanoparticles; Release Kinetics and Mathematical Modelling.

Authors:  Ravi Theaj Prakash Upputuri; Abul Kalam Azad Mandal
Journal:  Iran J Biotechnol       Date:  2017-12-29       Impact factor: 1.671

8.  Structural identification of novel glucoside and glucuronide metabolites of (-)-epigallocatechin-3-gallate in mouse urine using liquid chromatography/electrospray ionization tandem mass spectrometry.

Authors:  Shengmin Sang; Chung S Yang
Journal:  Rapid Commun Mass Spectrom       Date:  2008-11       Impact factor: 2.419

Review 9.  The challenge of developing green tea polyphenols as therapeutic agents.

Authors:  C Huo; S B Wan; W H Lam; L Li; Z Wang; K R Landis-Piwowar; D Chen; Q P Dou; T H Chan
Journal:  Inflammopharmacology       Date:  2008-10       Impact factor: 4.473

10.  Beneficial effects of green tea: a literature review.

Authors:  Sabu M Chacko; Priya T Thambi; Ramadasan Kuttan; Ikuo Nishigaki
Journal:  Chin Med       Date:  2010-04-06       Impact factor: 5.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.